MDxHealth SA Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by MDxHealth SA for the month of August 2023. The filing, dated August 10, 2023, serves to furnish a press release issued by the Company on August 9, 2023, which is attached as Exhibit 99.1.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a conduit for a press release rather than a financial statement containing quantitative data.
Material Changes
No material financial changes versus prior periods are detailed in the text of this filing. The content is limited to the notification of the attached press release.
Guidance, Outlook, and Risks
The filing explicitly states that the information in the attached press release is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, it is not subject to the liabilities of that Section nor incorporated by reference in other filings, except as expressly set forth. No specific guidance, outlook, or risk factors are detailed within the body of this Form 6-K.
Key Facts for Investor Verification
- The filing references a press release dated August 9, 2023, which contains the substantive information but is not included in the text of this summary.
- The information furnished is not deemed "filed" under Section 18 of the Exchange Act, limiting its legal liability status compared to standard financial reports.
- The Company is a foreign private issuer headquartered in Herstal, Belgium, filing under Commission File Number 001-40996.
- Investors must review the attached Exhibit 99.1 directly to obtain details regarding the announcement made on August 9, 2023.